litlas
Log inCreate account

Katherine A. High

Active 1989–2025

111
Papers
35,185
Citations
91
h-index
110
i10-index

Citations

Citations per year for Katherine A. High1990: 2 citations1991: 1 citations1993: 1 citations1994: 2 citations1995: 3 citations1996: 4 citations1997: 23 citations1998: 76 citations1999: 101 citations2000: 121 citations2001: 141 citations2002: 135 citations2003: 161 citations2004: 134 citations2005: 150 citations2006: 174 citations2007: 159 citations2008: 239 citations2009: 260 citations2010: 256 citations2011: 296 citations2012: 306 citations2013: 391 citations2014: 371 citations2015: 347 citations2016: 282 citations2017: 543 citations2018: 430 citations2019: 1,238 citations2020: 1,583 citations2021: 1,376 citations2022: 1,068 citations2023: 921 citations2024: 1,203 citations2025: 682 citations2026: 10 citations1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,288 citing papers, 36.1% of this breakdownChina: 795 citing papers, 8.7% of this breakdownUnited Kingdom: 662 citing papers, 7.3% of this breakdownGermany: 483 citing papers, 5.3% of this breakdownFrance: 431 citing papers, 4.7% of this breakdownItaly: 354 citing papers, 3.9% of this breakdownCanada: 271 citing papers, 3% of this breakdownNetherlands: 247 citing papers, 2.7% of this breakdownAustralia: 231 citing papers, 2.5% of this breakdownJapan: 215 citing papers, 2.4% of this breakdownSpain: 211 citing papers, 2.3% of this breakdownSwitzerland: 167 citing papers, 1.8% of this breakdown
0%36.1%Other 19.3%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology68.7%
  • Medicine22.3%
  • Neuroscience3.8%
  • Immunology and Microbiology1.6%
  • Engineering1.5%
  • Materials Science0.8%
  • Other1.3%

Topics

  • Virus-based gene therapy research14.7%
  • CRISPR and Genetic Engineering8.6%
  • RNA Interference and Gene Delivery7.6%
  • Retinal Development and Disorders5.9%
  • CAR-T cell therapy research4%
  • Viral Infectious Diseases and Gene Expression in Insects3.3%
  • Other55.9%

Coauthors

All papers

Open in search
  1. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial

    Authors: Stephen R. Russell, Jean Bennett, Jennifer Wellman, Daniel C. Chung, Zi-Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Sarah McCague, Dominique Cross, Kathleen Marshall, Jean Walshire, Taylor Kehoe, Hannah Reichert, Maria Davis, Leslie Raffini, Lindsey A. George, Fleur Hudson, Laura Dingfield, Xiaosong Zhu, Julia A. Haller, Elliott H. Sohn, Vinit B. Mahajan, Wanda Pfeifer, Michelle T. Weckmann, Chris A. Johnson, Dina Y. Gewaily, Arlene V. Drack, Edwin M. Stone, Katie Wachtel, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Albert M. Maguire - The Lancet 2017 cited by 1,889

  2. Gene therapy comes of age

    Authors: Cynthia E. Dunbar, Katherine A. High, J. Keith Joung, Donald B. Kohn, Keiya Ozawa, Michel Sadelain - Science 2018 cited by 1,378

  3. Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

    Authors: Catherine S. Manno, Glenn F. Pierce, Valder R. Arruda, Bertil Glader, Margaret V. Ragni, John E.J. Rasko, Margareth C. Ozelo, Keith Hoots, Philip M. Blatt, Barbara A. Konkle, Michael D. Dake, Robin Kaye, Mahmood Razavi, Albert Zajko, James L. Zehnder, Pradip K. Rustagi, Hiroyuki Nakai, Amy Chew, Debra G. B. Leonard, J Fraser Wright, Ruth Lessard, Jürg M. Sommer, Michael Tigges, Denise E. Sabatino, Alvin Luk, Haiyan Jiang, Federico Mingozzi, Linda Couto, Hildegund C.J. Ertl, Katherine A. High, Mark A. Kay - Nature Medicine 2006 cited by 2,135

  4. Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B

    Authors: Amit C. Nathwani, Edward G. D. Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Pie, Chris F. Harrington, James O’Beirne, Keith Smith, John Pasi, Bertil Glader, Pradip K. Rustagi, Catherine Y. Ng, Mark A. Kay, Junfang Zhou, Yunyu Spence, Christopher L. Morton, James A. Allay, John B. Coleman, Susan Sleep, John M. Cunningham, Deo Kumar Srivastava, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, John T. Gray, Ulrike M. Reiss, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2011 cited by 1,843

  5. Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

    Authors: Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lhériteau, Nishal Patel, Deepak B. Thimiri Govinda Raj, Anne Riddell, Jun Pie, Savita Rangarajan, David Bevan, Michael Recht, Yu‐Min Shen, Kathleen G. Halka, Etiena Basner‐Tschakarjan, Federico Mingozzi, Katherine A. High, James A. Allay, Mark A. Kay, Catherine Y. Ng, Junfang Zhou, Maria Cancio, Christopher L. Morton, John T. Gray, Deo Kumar Srivastava, Arthur W. Nienhuis, Andrew M. Davidoff - New England Journal of Medicine 2014 cited by 1,250

  6. Immune responses to AAV vectors: overcoming barriers to successful gene therapy

    Authors: Federico Mingozzi, Katherine A. High - Blood 2013 cited by 920

  7. Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant

    Authors: Lindsey A. George, Spencer K. Sullivan, Adam Giermasz, John E.J. Rasko, Benjamin J. Samelson‐Jones, Jonathan M. Ducore, Adam Cuker, Lisa Sullivan, Suvankar Majumdar, Jerome Teitel, Catherine McGuinn, Margaret V. Ragni, Alvin Luk, Daniel J. Hui, J. Fraser Wright, Yifeng Chen, Yun Liu, Katie Wachtel, Angela Winters, Stefan Tiefenbacher, Valder R. Arruda, Johannes C.M. van der Loo, Olga Zelenaia, Daniel M. Takefman, Marcus E. Carr, Linda B. Couto, Xavier M. Anguela, Katherine A. High - New England Journal of Medicine 2017 cited by 759

  8. Gene Therapy

    Authors: Katherine A. High, Maria Grazia Roncarolo - New England Journal of Medicine 2019 cited by 525

  9. Entering the Modern Era of Gene Therapy

    Authors: Xavier M. Anguela, Katherine A. High - Annual Review of Medicine 2018 cited by 468

  10. Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation–Associated Inherited Retinal Dystrophy

    Authors: Albert M. Maguire, Stephen R. Russell, Jennifer Wellman, Daniel C. Chung, Zi‐Fan Yu, Amy Tillman, Janet Wittes, Julie Pappas, Okan U. Elci, Kathleen Marshall, Sarah McCague, Hannah Reichert, Maria Davis, Francesca Simonelli, Bart P. Leroy, J. Fraser Wright, Katherine A. High, Jean Bennett - Ophthalmology 2019 cited by 391

  11. Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis

    Authors: Albert M. Maguire, Francesca Simonelli, Eric A. Pierce, Edward N. Pugh, Federico Mingozzi, Jeannette Bennicelli, Sandro Banfi, Kathleen Marshall, Francesco Testa, Enrico Maria Surace, Settimio Rossi, Arkady Lyubarsky, Valder R. Arruda, Barbara A. Konkle, Edwin M. Stone, Junwei Sun, Jonathan B. Jacobs, Lou F Dell'Osso, Richard W. Hertle, Jian‐xing Ma, T. Michael Redmond, Xiaosong Zhu, Bernd Hauck, Olga Zelenaia, Kenneth S. Shindler, Maureen G. Maguire, J. Fraser Wright, Nicholas J. Volpe, Jennifer Wellman McDonnell, Alberto Auricchio, Katherine A. High, Jean Bennett - New England Journal of Medicine 2008 cited by 2,137

  12. CD8+ T-cell responses to adeno-associated virus capsid in humans

    Authors: Federico Mingozzi, Marcela V. Maus, Daniel J. Hui, Denise E. Sabatino, Samuel L. Murphy, John E.J. Rasko, Margaret V. Ragni, Catherine S. Manno, Jürg M. Sommer, Haiyan Jiang, Glenn F. Pierce, Hildegund C.J. Ertl, Katherine A. High - Nature Medicine 2007 cited by 726

  13. Multiyear Factor VIII Expression after AAV Gene Transfer for Hemophilia A

    Authors: Lindsey A. George, Paul E. Monahan, M. Elaine Eyster, Spencer K. Sullivan, Margaret V. Ragni, Stacy E. Croteau, John E.J. Rasko, Michael Recht, Benjamin J. Samelson‐Jones, Amy MacDougall, Kristen Jaworski, Robert Noble, Marla Curran, Klaudia Kuranda, Federico Mingozzi, Tiffany Chang, Kathleen Z. Reape, Xavier M. Anguela, Katherine A. High - New England Journal of Medicine 2021 cited by 253

  14. Long-Term Follow-Up of the First in Human Intravascular Delivery of AAV for Gene Transfer: AAV2-hFIX16 for Severe Hemophilia B

    Authors: Lindsey A. George, Margaret V. Ragni, John E.J. Rasko, Leslie Raffini, Benjamin J. Samelson‐Jones, Margareth C. Ozelo, Maria Hazbon, Alexa R. Runowski, Jennifer Wellman, Katie Wachtel, Yifeng Chen, Xavier M. Anguela, Klaudia Kuranda, Federico Mingozzi, Katherine A. High - Molecular Therapy 2020 cited by 209

  15. Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial

    Authors: Albert M. Maguire, Katherine A. High, Alberto Auricchio, J. Fraser Wright, Eric A. Pierce, Francesco Testa, Federico Mingozzi, Jeannette Bennicelli, Gui‐Shuang Ying, Settimio Rossi, Ann Fulton, Kathleen Marshall, Sandro Banfi, Daniel C. Chung, Jessica I. W. Morgan, Bernd Hauck, Olga Zelenaia, Xiaosong Zhu, Leslie Raffini, Frauke Coppieters, Elfride De Baere, Kenneth S. Shindler, Nicholas J. Volpe, Enrico Maria Surace, Carmela Acerra, Arkady Lyubarsky, T. Michael Redmond, Edwin M. Stone, Junwei Sun, Jennifer Wellman McDonnell, Bart P. Leroy, Francesca Simonelli, Jean Bennett - The Lancet 2009 cited by 858

  16. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges

    Authors: Federico Mingozzi, Katherine A. High - Nature Reviews Genetics 2011 cited by 901

  17. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial

    Authors: Jean Bennett, Jennifer Wellman, Kathleen Marshall, Sarah McCague, Manzar Ashtari, Julie DiStefano‐Pappas, Okan U. Elci, Daniel C. Chung, Junwei Sun, J. Fraser Wright, Dominique Cross, Puya Aravand, Laura Cyckowski, Jeannette Bennicelli, Federico Mingozzi, Alberto Auricchio, Eric A. Pierce, Jason Ruggiero, Bart P. Leroy, Francesca Simonelli, Katherine A. High, Albert M. Maguire - The Lancet 2016 cited by 456

  18. Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease

    Authors: Albert M. Maguire, Stephen R. Russell, Daniel C. Chung, Zi‐Fan Yu, Amy Tillman, Arlene V. Drack, Francesca Simonelli, Bart P. Leroy, Kathleen Z. Reape, Katherine A. High, Jean Bennett - Ophthalmology 2021 cited by 188

  19. Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys

    Authors: Federico Mingozzi, Xavier M. Anguela, Giulia Pavani, Yifeng Chen, Robert J. Davidson, Daniel J. Hui, Mustafa N. Yazicioglu, Liron Elkouby, Christian Hinderer, Armida Faella, Carolann Howard, Alex Tai, Gregory M. Podsakoff, Shangzhen Zhou, Etiena Basner‐Tschakarjan, J. Fraser Wright, Katherine A. High - Science Translational Medicine 2013 cited by 344

  20. Effects of transient immunosuppression on adenoassociated, virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy

    Authors: Haiyan Jiang, Linda B. Couto, Susannah Patarroyo‐White, Tongyao Liu, Dea Nagy, Joseph Vargas, Shangzhen Zhou, Ciaran D. Scallan, Jürg M. Sommer, Sharmila Vijay, Federico Mingozzi, Katherine A. High, Glenn F. Pierce - Blood 2006 cited by 320

  21. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B

    Authors: Catherine S. Manno, Ah Keng Chew, S Hutchison, Peter J. Larson, Roland W. Herzog, V. R. Arruda, Shing Jen Tai, Margaret V. Ragni, Alexis A. Thompson, Margareth C. Ozelo, Linda B. Couto, Debra G. B. Leonard, Freddie A. Johnson, Alan McClelland, Ciaran D. Scallan, Erik D. Skarsgard, Alan W. Flake, Mark A. Kay, Katherine A. High, Bertil Glader - Blood 2003 cited by 747

  22. AAV-1–mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells

    Authors: Federico Mingozzi, J. J. M. Meulenberg, Daniel J. Hui, Etiena Basner‐Tschakarjan, Nicole C. Hasbrouck, Shyrie Edmonson, Natalie A. Hutnick, Michael R. Betts, John J.P. Kastelein, Erik S.G. Stroes, Katherine A. High - Blood 2009 cited by 284

  23. Clinical development of gene therapy: results and lessons from recent successes

    Authors: Sandeep Kumar, David M. Markusic, Moanaro Biswas, Katherine A. High, Roland W. Herzog - Molecular Therapy — Methods & Clinical Development 2016 cited by 229

  24. Assessing the potential for AAV vector genotoxicity in a murine model

    Authors: Hojun Li, Nirav Malani, Shari R Hamilton, Alexander Schlachterman, Giulio Bussadori, Shyrie E. Edmonson, Rachel Shah, Valder R. Arruda, Federico Mingozzi, J. Fraser Wright, Frederic D. Bushman, Katherine A. High - Blood 2010 cited by 228